Unnatural Products Secures $45M to Advance Peptides
SANTA CRUZ, Calif., March 16, 2026 Unnatural Products has announced the successful closing of a $45 million Series B...
Therapeutic Innovation
Advertisement
CTT Pharma Publishes Peer-Reviewed Drug Delivery Research
BOSTON, Massachusetts — December 16, 2025 — CTT Pharmaceutical Holdings, Inc. (CTT Pharma) announced that its scientific team has...
Zenas BioPharma Showcases Autoimmune Advances at Q4 2025 Events
Dateline — WALTHAM, Mass., November 11, 2025:Zenas BioPharma, Inc. (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company dedicated to developing...
AB Science Secures €2.8 Million in Private Placement to Advance Clinical Pipeline
PARIS, October 17, 2025 AB Science S.A., a biopharmaceutical company focused on discovering, developing, and marketing protein kinase inhibitors,...
Andelyn Biosciences Partners with Tern Therapeutics for Late-Stage Manufacturing of AAV Gene Therapy for CLN2 Batten Disease
Andelyn Biosciences, a leading cell and gene therapy CDMO, has partnered with Tern Therapeutics to perform late-stage Process Performance...
Advertisement
